Why the study?
Does off-pump CABG reduce the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization in patients undergoing CABG compared to on-pump CABG?
Does off-pump CABG reduce the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization in patients undergoing CABG compared to on-pump CABG?
At 5 years of follow-up, off-pump CABG does not significantly differ from on-pump CABG in reducing major adverse cardiovascular and renal events.
Answers are grounded in this paper and cite their sources.
Neither technique preferred on this outcome; confirms long-term equivalence between off-pump and on-pump CABG.
In our trial, the rate of the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 years of follow-up was similar among patients who underwent off-pump CABG and those who underwent on-pump CABG. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294 .).
No takes yet. Share an insight, caveat, or question.
Lamy et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: